Moreover, the formation of complexes between IGF-IR and specific antibodies lead to an increase of soluble free IGF-I and IGF-II that can leave the circulation to stimulate IGF receptors present on cell surface of cancer cells [104]. This evidence concerns the gene IGF1 and cancer.